Posttraumatic stress disorder: A missed link between psychiatric and cardiovascular morbidity?

被引:21
作者
Cotter, G
Milo-Cotter, O
Rubinstein, D
Shemesh, E
机构
[1] Duke Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Durham, NC 27710 USA
[2] Elmhurst Med Ctr, Dept Cardiol, New York, NY USA
[3] CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA
[4] CUNY Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA
[5] CUNY Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA
关键词
D O I
10.1017/S109285290001066X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Posttraumatic stress disorder (PTSD) symptoms may develop as a result of an acute, life-threatening traumatic event. Such acute events are quite common in patients with cardiovascular illnesses (ie, a myocardial infarction, acute exacerbations of heart failure or edema). Indeed, PTSD symptoms have been described in a substantial minority of patients who had such events (10% to 25%), and have been shown to be associated with medical morbidity and with non-adherence to medications. This review summarizes available information about these symptoms in patients with cardiovascular illnesses. It also describes the importance of recognizing PTSD as a distinct psychiatric disorder (that can be addressed by specific treatments) and as an important compounding factor in studies of psychopathology in cardiovascular patients. In particular, an argument is made that the understanding of depressive disorders in patients with cardiovascular illnesses should incorporate conceptual and treatment information from the emotional trauma literature if indeed depressive and anxiety disorders are to be successfully treated in these patients. The authors conclude with a description of the challenges and promise of an effort to implement a clinical program to screen for PTSD symptoms in patients with cardiovascular illnesses, and with recommendations for future efforts.
引用
收藏
页码:129 / 136
页数:10
相关论文
共 44 条
[1]  
[Anonymous], 2002, TREATING TRAUMA SURV
[2]  
[Anonymous], 2000, DIAGN STAT MAN MENT
[3]   Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis [J].
Barth, J ;
Schumacher, M ;
Herrmann-Lingen, C .
PSYCHOSOMATIC MEDICINE, 2004, 66 (06) :802-813
[4]  
Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106
[5]  
BILLINGS RF, 1981, ACTA MED SCAND, P46
[6]   Efficacy and safety of sertraline treatment of posttraumatic stress disorder - A randomized controlled trial [J].
Brady, K ;
Pearlstein, T ;
Asnis, GM ;
Baker, D ;
Rothbaum, B ;
Sikes, CR ;
Farfel, GM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (14) :1837-1844
[7]   Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma [J].
Breslau, N ;
Davis, GC ;
Schultz, LR .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (03) :289-294
[8]  
CANNER PL, 1980, NEW ENGL J MED, V303, P1038
[9]   Lack of aspirin effect: Aspirin resistance or resistance to taking aspirin? [J].
Cotter, G ;
Shemesh, E ;
Zehavi, M ;
Dinur, I ;
Rudnick, A ;
Milo, O ;
Vered, Z ;
Krakover, R ;
Kaluski, E ;
Kornberg, A .
AMERICAN HEART JOURNAL, 2004, 147 (02) :293-300
[10]   Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder [J].
Davidson, JRT ;
Rothbaum, BO ;
van der Kolk, BA ;
Sikes, CR ;
Farfel, GM .
ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (05) :485-492